Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.37 USD | -12.26% | -15.02% | -43.57% |
08:21pm | Altimmune Shares Decline After Guggenheim Downgrade | MT |
01:26pm | Guggenheim Downgrades Altimmune to Neutral From Buy | MT |
Sales 2024 * | 35.71M 48.81M | Sales 2025 * | 28.57M 39.05M | Capitalization | 515M 703M |
---|---|---|---|---|---|
Net income 2024 * | -61M -83.36M | Net income 2025 * | -147M -201M | EV / Sales 2024 * | 11.8 x |
Net cash position 2024 * | 91.94M 126M | Net cash position 2025 * | 285M 389M | EV / Sales 2025 * | 8.05 x |
P/E ratio 2024 * |
-7.79
x | P/E ratio 2025 * |
-5.21
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Altimmune, Inc.
1 day | -12.47% | ||
1 week | -15.02% | ||
Current month | -37.64% | ||
1 month | -37.95% | ||
3 months | -37.34% | ||
6 months | +165.60% | ||
Current year | -43.57% |
Managers | Title | Age | Since |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 18-11-29 |
Director of Finance/CFO | 66 | 21-12-30 | |
Anthony Blandin
CMP | Compliance Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 10-03-31 |
Mack Gill
BRD | Director/Board Member | 72 | 04-07-31 |
Philip Hodges
BRD | Director/Board Member | 56 | 03-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 6.335 | -12.74% | 3 609 941 |
24-04-26 | 7.26 | +0.83% | 2,250,760 |
24-04-25 | 7.2 | +1.69% | 2,316,111 |
24-04-24 | 7.08 | -6.47% | 2,205,337 |
24-04-23 | 7.57 | +1.34% | 3,131,602 |
Delayed Quote Nasdaq, April 29, 2024 at 03:16 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.57% | 515M | |
-2.93% | 103B | |
+1.39% | 95.28B | |
+1.46% | 22.15B | |
-16.01% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.20% | 16.05B | |
+4.82% | 13.68B | |
+33.07% | 12.17B |
- Stock Market
- Equities
- ALT Stock